A Study To Identify Genomic Factors Influencing COVID-19 Disease Burden In Latinx Individuals

Overview

About this study

The purpose of this study is to focus on identifying genomic factors that are associated with COVID-19 infection and severity in Latinx individuals. The hypothesis is that there are genomic variants that can predict the risk of disease infection and severity in Latinx individuals. Analysis of GWAS data (from SPS Biobank Study IRB 12-008503) for patients with various COVID-19 disease severity, stratified on age, gender and relevant clinical co-morbidities such as metabolic or cardiovascular disorders will be performed that may be used to potentially guide screening, diagnosis and clinical intervention in Latinx individuals in the context of COVID-19.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

RETROSPECTIVE STUDY - NO PARTICIPANT CONTACT

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Elena Anna De Filippis, M.D., Ph.D.

Contact us for the latest status

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions